News
2022/06/22
On 22.06.2022, the Federal Council decided to lift the ban on using cannabis for medical purposes. This means simplified access for patients, as an exceptional permit from the Federal Office of Public Health will no longer be required for medical prescriptions. Pharmacies will also no longer require an exceptional authorization from the FOPH, and cannabis products and preparations containing THC can now be dispensed with a narcotic prescription from a doctor in every pharmacy.
In addition, it will be possible to export THC-containing cannabis products for medical purposes.
As long-standing producers of THC-containing Swiss cannabis extracts, we look forward to hearing from you!
2020/06/08 RTS
Report (French) on the medical cannabis market.
2020/06 Schweizer Bauer
Article about medical hemp in Switzerland and a short interview with Armin Käser.
2020/02/12 Berner Landbote
Interview with Markus Lüdi about Cannapharm AG.
2019/12/09 SRF ECO
Report on the economic potential of medical cannabis for Switzerland.
2019/11/21 Tages-Anzeiger
Article in the Tages-Anzeiger about the hemp pioneer Markus Lüdi.
2019 Cannabis in dementia
Pilot study by Broers et al. (2019) (English), treatment of dementia patients with our ethanolic and oily cannabis extracts.
2018/03/13 Motion Nationalrat
Motion submitted by Christa Markwalder on thecultivation and export of medical cannabis.
2018/09/20 Aargauer Zeitung
Sabotaged medicine: Interesting article about the legal difficulties that Cannapharm AG, among others, was confronted with by the BAG.
Here you can find the complete online version with further information.
2018/09/10 BBC
Report of the BBC (English) about Markus Lüdi (Cannapharm AG), the use of the products (including patient perspective).
2018/05/18 Berner Zeitung
BZ reports about Cannapharm AG, its history and current difficulties in dealing with authorities.
2018/02/17 Schweizer Bauer
Because the demand for medicinal hemp has also grown strongly abroad, Cannapharm AG is looking for local producers in case the export is approved.
2017/05/04 Motion Nationalrat
Motion submitted by Thomas Amman for the medical distribution of cannabis as a drug to chronically ill patients. Lower healthcare costs and less bureaucracy.